Avenir Corporation’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-20,080
| Closed | -$987K | – | 67 |
|
|
2018
Q3 | $987K | Hold |
20,080
| – | – | 0.11% | 50 |
|
|
2018
Q2 | $644K | Sell |
20,080
-2,570
| -11% | -$82.4K | 0.07% | 53 |
|
|
2018
Q1 | $706K | Buy |
22,650
+6,780
| +43% | +$211K | 0.08% | 53 |
|
|
2017
Q4 | $724K | Buy |
15,870
+3,750
| +31% | +$171K | 0.07% | 55 |
|
|
2017
Q3 | $455K | Buy |
12,120
+2,100
| +21% | +$78.8K | 0.04% | 58 |
|
|
2017
Q2 | $478K | Buy |
10,020
+2,120
| +27% | +$101K | 0.04% | 58 |
|
|
2017
Q1 | $360K | Hold |
7,900
| – | – | 0.03% | 61 |
|
|
2016
Q4 | $255K | Buy |
7,900
+400
| +5% | +$12.9K | 0.02% | 64 |
|
|
2016
Q3 | $257K | Buy |
+7,500
| New | +$257K | 0.02% | 62 |
|
|
2016
Q1 | – | Sell |
-2,750
| Closed | -$211K | – | 69 |
|
|
2015
Q4 | $211K | Buy |
+2,750
| New | +$211K | 0.02% | 67 |
|